Prostate Cancer Clinical Trial

Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

Summary

This clinical study was to determine if the use of 6 months of total androgen suppression (hormonal therapy) when added to radiation therapy for localized-high risk prostate cancer would improve overall survival.

View Full Description

Full Description

This was a randomized study comparing external beam radiation therapy with total androgen ablation for 6 months with radiation therapy alone. Drugs were given 2 months prior, 2 months during, and 2 months after radiation therapy. Eulexin and Lupron or Zoladex was used in this study.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Biopsy proven prostate cancer
Negative bone scan
Lymph nodes by CT or MRI
Adequate blood work
Performance Status - ECOG 0-1
Life expectancy of at least 10 years
>40 years of age

Exclusion Criteria:

Prior history of malignancy
Prior hormonal therapy or chemotherapy
Prior pelvic radiation therapy
Unable to tolerate lying still 5-10 minutes/day

Study is for people with:

Prostate Cancer

Phase:

Phase 3

Estimated Enrollment:

206

Study ID:

NCT00116220

Recruitment Status:

Completed

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Dana-Farber Cancer Institute
Boston Massachusetts, 02115, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Phase:

Phase 3

Estimated Enrollment:

206

Study ID:

NCT00116220

Recruitment Status:

Completed

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider